Try it
Pharmacology · Chemotherapy: apremilast
Sample itemA patient with psoriatic arthritis is given apremilast, an oral small molecule that inhibits phosphodiesterase 4. Which adverse effects are characteristic?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Diarrhoea, nausea, weight loss and depression
Apremilast inhibits PDE4, raising cAMP in immune cells and lowering production of TNF, IL-17 and IL-23. It requires no routine laboratory monitoring, and its common adverse effects are diarrhoea, nausea, headache, weight loss and depression. It is used in psoriasis, psoriatic arthritis and Behcet oral ulcers.
Option by option
A. Bradycardia and macular oedema
Bradycardia with macular oedema is typical of fingolimod.
B. Diarrhoea, nausea, weight loss and depression (correct)
Correct. Gastrointestinal upset, weight loss and mood change are typical of PDE4 inhibition.
C. Neutropenia and opportunistic infections
Neutropenia with opportunistic infection is a concern with immunosuppressants such as azathioprine.
D. Hepatic necrosis and pancreatitis
Hepatic necrosis and pancreatitis are not characteristic of apremilast.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?